Gujarat Themis Biosyn’s Promoter is planning to offload 9.79% (14,23,000 equity shares) of its shareholding in the Company to comply with the minimum public shareholding (MPS) requirements as prescribed by Securities and Exchange Board of India (SEBI).
Gujarat Themis Biosyn is a biotech and synthetic product manufacturing company, having plants at Vapi, Hyderabad, with group turnover of over $40 million. The company has world-wide exports to satisfied customers, having customised facility for all products.
| Company Name | CMP |
|---|---|
| Sun Pharma Inds. | 1675.20 |
| Dr. Reddys Lab | 1235.40 |
| Cipla | 1238.30 |
| Zydus Lifesciences | 942.55 |
| Lupin | 2324.25 |
| View more.. | |
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: